290 related articles for article (PubMed ID: 22169643)
1. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis].
Wang F; Xie XJ; Piao YS; Liu B; Wang LD
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):537-41. PubMed ID: 22169643
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status.
Vasavi M; Ponnala S; Gujjari K; Boddu P; Bharatula RS; Prasad R; Ahuja YR; Hasan Q
Tumori; 2006; 92(2):155-62. PubMed ID: 16724696
[TBL] [Abstract][Full Text] [Related]
3. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.
Wang J; Sasco AJ; Fu C; Xue H; Guo G; Hua Z; Zhou Q; Jiang Q; Xu B
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):118-25. PubMed ID: 18199718
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
[TBL] [Abstract][Full Text] [Related]
5. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism and folate intake in esophageal squamous cell carcinoma.
Chen J; Huang ZJ; Duan YQ; Xiao XR; Jiang JQ; Zhang R
Asian Pac J Cancer Prev; 2012; 13(10):5303-6. PubMed ID: 23244153
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability analysis and its correlation with hMLH1 repair gene hypermethylation status in esophageal pathologies including cancers.
Vasavi M; Kiran V; Ravishankar B; Prabhakar B; Ahuja YR; Hasan Q
Cancer Biomark; 2010; 7(1):1-10. PubMed ID: 21045259
[TBL] [Abstract][Full Text] [Related]
7. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G
Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus.
Guo M; Ren J; House MG; Qi Y; Brock MV; Herman JG
Clin Cancer Res; 2006 Aug; 12(15):4515-22. PubMed ID: 16899597
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
Viswanathan M; Tsuchida N; Shanmugam G
Int J Cancer; 2003 May; 105(1):41-6. PubMed ID: 12672028
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma.
Czerninski R; Krichevsky S; Ashhab Y; Gazit D; Patel V; Ben-Yehuda D
Oral Dis; 2009 Apr; 15(3):206-13. PubMed ID: 19207881
[TBL] [Abstract][Full Text] [Related]
12. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma.
Zuo C; Zhang H; Spencer HJ; Vural E; Suen JY; Schichman SA; Smoller BR; Kokoska MS; Fan CY
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):484-90. PubMed ID: 19786217
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions.
Guida M; Sanguedolce F; Bufo P; Di Spiezio Sardo A; Bifulco G; Nappi C; Pannone G
Eur J Gynaecol Oncol; 2009; 30(3):267-70. PubMed ID: 19697618
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in esophageal squamous cell carcinoma is not associated with hMLH1 promoter hypermethylation.
Hayashi M; Tamura G; Jin Z; Kato I; Sato M; Shibuya Y; Yang S; Motoyama T
Pathol Int; 2003 May; 53(5):270-6. PubMed ID: 12713560
[TBL] [Abstract][Full Text] [Related]
15. Gene Promoter Methylation in Endometrial Carcinogenesis.
Cornel KMC; Wouters K; Van de Vijver KK; van der Wurff AAM; van Engeland M; Kruitwagen RFPM; Pijnenborg JMA
Pathol Oncol Res; 2019 Apr; 25(2):659-667. PubMed ID: 30430425
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
Puri SK; Si L; Fan CY; Hanna E
Am J Otolaryngol; 2005; 26(1):12-7. PubMed ID: 15635575
[TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.
Xiong HL; Liu XQ; Sun AH; He Y; Li J; Xia Y
Asian Pac J Cancer Prev; 2013; 14(5):3139-42. PubMed ID: 23803092
[TBL] [Abstract][Full Text] [Related]
18. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
